Skip to main content
Figure 8 | BMC Cancer

Figure 8

From: Enhanced antiproliferative and apoptotic response to combined treatment of γ-tocotrienol with erlotinib or gefitinib in mammary tumor cells

Figure 8

Western blot analysis of total and phosphorylated ErbB receptor levels treated with γ-tocotrienol (γT 3 ), erlotinib (E) or gefitinib (G) either alone or in combination. +SA mammary tumor cells were plated at a density of 1 × 106 cells/100-mm culture dish and treated with control or treatment serum-free defined media containing EGF as mitogen. After a 4-day incubation period, whole cell lysates were subjected to PAGE followed by Western blot analysis for total and phosphorylated (active) ErbB receptor levels. Each Western blot is a representative example of data obtained for experiments that were repeated at least three times.

Back to article page